DP
PRAH

DSAM Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

DSAM Partners’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-103,500
Closed -$2.51K – 56
2014
Q4 		$2.51K Buy
+103,500
New +$2.33M 0.66% 27

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DSAM Partners's PRAH Position: Q1 2015 in Review

DSAM Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2015, closing a stake of 103,500 shares — an estimated $2.51K sold.

DSAM Partners first reported a position in PRAH in Q4 2014 and held it in 1 quarter. The position peaked at $2.51K in Q4 2014. 72 funds tracked by Wall St. Rank hold PRAH as of Q1 2015.

  • DSAM Partners reported no remaining PRA Health Sciences, Inc. position as of Q1 2015 after selling out during the quarter.
  • DSAM Partners sold 103,500 PRA Health Sciences, Inc. shares in Q1 2015, an estimated $2.51K.
  • DSAM Partners first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 1 quarter.
  • DSAM Partners's PRA Health Sciences, Inc. position peaked at $2.51K in Q4 2014.
  • 72 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2015.

Based on DSAM Partners's 13F filing for Q1 2015, filed 15 May 2015.